| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 116.93M | 62.58M | 60.54M | 114.17M | 90.28M |
| Gross Profit | 15.91M | 24.76M | 8.95M | 22.93M | 18.34M |
| EBITDA | -29.92M | -7.10M | -29.05M | -98.38M | -2.11M |
| Net Income | -32.49M | -17.84M | -40.97M | -109.68M | -15.13M |
Balance Sheet | |||||
| Total Assets | 221.44M | 223.09M | 226.02M | 271.45M | 309.71M |
| Cash, Cash Equivalents and Short-Term Investments | 11.03M | 33.37M | 2.35M | 8.01M | 4.18M |
| Total Debt | 43.86M | 51.19M | 68.22M | 81.48M | 75.38M |
| Total Liabilities | 113.73M | 106.88M | 157.65M | 166.02M | 147.07M |
| Stockholders Equity | 107.99M | 113.17M | 69.13M | 102.89M | 156.22M |
Cash Flow | |||||
| Free Cash Flow | -38.52M | -17.50M | -6.22M | -21.90M | -14.52M |
| Operating Cash Flow | -38.20M | -17.48M | -5.99M | -11.20M | -11.18M |
| Investing Cash Flow | -676.00K | -2.66M | -580.00K | -34.57M | -25.97M |
| Financing Cash Flow | 17.59M | 50.78M | 633.00K | 49.45M | -5.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$262.02B | 287.26 | 9.01% | 0.54% | 20.63% | 48.18% | |
68 Neutral | HK$1.99B | 39.85 | 11.92% | 2.53% | 19.80% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$540.00M | 164.44 | -0.09% | ― | 21.56% | 161.29% | |
54 Neutral | HK$4.15B | 114.72 | -11.77% | 0.24% | 0.94% | ― | |
48 Neutral | HK$506.00M | 16.66 | 4.11% | ― | 5.62% | 37.91% | |
46 Neutral | HK$92.70M | -2.22 | -30.01% | ― | -58.81% | -10.51% |